Journal Article
C. M. Roe, Babulal, G. M., Mishra, S., Gordon, B. A., Stout, S. H., Ott, B. R., Carr, D. B., Ances, B. M., Morris, J. C., and Benzinger, T. L. S.,
“Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.”,
J Alzheimers Dis, vol. 61, no. 2, pp. 509-513, 2018.
S. L. Allison, Fagan, A. M., Morris, J. C., and Head, D.,
“Spatial Navigation in Preclinical Alzheimer's Disease.”,
J Alzheimers Dis, vol. 52, no. 1, pp. 77-90, 2016.
F. Rahmani, Wang, Q., McKay, N. S., Keefe, S., Hantler, N., Hornbeck, R., Wang, Y., Hassenstab, J., Schindler, S., Xiong, C., Morris, J. C., Benzinger, T. L. S., and Raji, C. A.,
“Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity.”,
J Alzheimers Dis, vol. 86, no. 4, pp. 1831-1848, 2022.
P. Chatterjee, Lim, W. L. F., Shui, G., Gupta, V. B., James, I., Fagan, A. M., Xiong, C., Sohrabi, H. R., Taddei, K., Brown, B. M., Benzinger, T., Masters, C., Snowden, S. G., Wenk, M. R., Bateman, R. J., Morris, J. C., and Martins, R. N.,
“Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study.”,
J Alzheimers Dis, vol. 50, no. 3, pp. 887-94, 2016.
G. M. Babulal, Stout, S. H., Head, D., Holtzman, D. M., Fagan, A. M., Morris, J. C., and Roe, C. M.,
“Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report.”,
J Alzheimers Dis, vol. 58, no. 3, pp. 675-680, 2017.
J. M. Castellano, Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., Goate, A. M., Bales, K. R., Paul, S. M., Bateman, R. J., and Holtzman, D. M.,
“Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.”,
Sci Transl Med, vol. 3, no. 89, p. 89ra57, 2011.
V. Thirunavu, McCullough, A., Su, Y., Flores, S., Dincer, A., Morris, J. C., Cruchaga, C., Benzinger, T. L. S., and Gordon, B. A.,
“Higher Body Mass Index Is Associated with Lower Cortical Amyloid-β Burden in Cognitively Normal Individuals in Late-Life.”,
J Alzheimers Dis, vol. 69, no. 3, pp. 817-827, 2019.
L. Jones, Holmans, P. A., Hamshere, M. L., Harold, D., Moskvina, V., Ivanov, D., Pocklington, A., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Pahwa, J. Singh, Jones, N., Stretton, A., Morgan, A. R., Lovestone, S., Powell, J., Proitsi, P., Lupton, M. K., Brayne, C., Rubinsztein, D. C., Gill, M., Lawlor, B., Lynch, A., Morgan, K., Brown, K. S., Passmore, P. A., Craig, D., McGuinness, B., Todd, S., Holmes, C., Mann, D., A Smith, D., Love, S., Kehoe, P. G., Mead, S., Fox, N., Rossor, M., Collinge, J., Maier, W., Jessen, F., Schürmann, B., Heun, R., Kölsch, H., van den Bussche, H., Heuser, I., Peters, O., Kornhuber, J., Wiltfang, J., Dichgans, M., Frölich, L., Hampel, H., Hüll, M., Rujescu, D., Goate, A. M., Kauwe, J. S. K., Cruchaga, C., Nowotny, P., Morris, J. C., Mayo, K., Livingston, G., Bass, N. J., Gurling, H., McQuillin, A., Gwilliam, R., Deloukas, P., Al-Chalabi, A., Shaw, C. E., Singleton, A. B., Guerreiro, R., Mühleisen, T. W., Nöthen, M. M., Moebus, S., Jöckel, K. - H., Klopp, N., Wichmann, H. - E., Rüther, E., Carrasquillo, M. M., V Pankratz, S., Younkin, S. G., Hardy, J., O'Donovan, M. C., Owen, M. J., and Williams, J.,
“Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.”,
PLoS One, vol. 5, no. 11, p. e13950, 2010.
A. Keleman, Wisch, J. K., Bollinger, R. M., Grant, E. A., Benzinger, T. L., Morris, J. C., Ances, B. M., and Stark, S. L.,
“Falls Associate with Neurodegenerative Changes in ATN Framework of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 77, no. 2, pp. 843-853, 2020.
D. Head, Bugg, J. M., Goate, A. M., Fagan, A. M., Mintun, M. A., Benzinger, T., Holtzman, D. M., and Morris, J. C.,
“Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.”,
Arch Neurol, vol. 69, no. 5, pp. 636-43, 2012.
G. M. McKhann, Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., Thies, B., Weintraub, S., and Phelps, C. H.,
“The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.”,
Alzheimers Dement, vol. 7, no. 3, pp. 263-9, 2011.
G. M. Babulal, Chen, S., Williams, M. M., Trani, J. - F., Bakhshi, P., Chao, G. L., Stout, S. H., Fagan, A. M., Benzinger, T. L. S., Holtzman, D. M., Morris, J. C., and Roe, C. M.,
“Depression and Alzheimer's Disease Biomarkers Predict Driving Decline.”,
J Alzheimers Dis, vol. 66, no. 3, pp. 1213-1221, 2018.
J. Timsina, Gomez-Fonseca, D., Wang, L., Do, A., Western, D., Álvarez, I., Aguilar, M., Pastor, P., Henson, R. L., Herries, E., Xiong, C., Schindler, S. E., Fagan, A. M., Bateman, R. J., Farlow, M., Morris, J. C., Perrin, R., Moulder, K., Hassenstab, J., Chhatwal, J., Mori, H., Sung, Y. Ju, and Cruchaga, C.,
“Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach.”,
J Alzheimers Dis, vol. 89, no. 1, pp. 193-207, 2022.
A. P. Ingber, Hassenstab, J., Fagan, A. M., Benzinger, T. L. S., Grant, E. A., Holtzman, D. M., Morris, J. C., and Roe, C. M.,
“Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 52, no. 3, pp. 1055-64, 2016.
P. Lewczuk, Matzen, A., Blennow, K., Parnetti, L., Molinuevo, J. Luis, Eusebi, P., Kornhuber, J., Morris, J. C., and Fagan, A. M.,
“Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 55, no. 2, pp. 813-822, 2017.
J. L. Del-Aguila, Fernández, M. Victoria, Schindler, S., Ibanez, L., Deming, Y., Ma, S., Saef, B., Black, K., Budde, J., Norton, J., Chasse, R., Harari, O., Goate, A., Xiong, C., Morris, J. C., and Cruchaga, C.,
“Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline.”,
J Alzheimers Dis, vol. 62, no. 2, pp. 745-756, 2018.
J. C. Morris, Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., and Mintun, M. A.,
“APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.”,
Ann Neurol, vol. 67, no. 1, pp. 122-31, 2010.
] 